Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Impel Pharmaceuticals (IMPLQ)
OTHER OTC:IMPLQ
Holding IMPLQ?
Track your performance easily
IMPLQ Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range<$0.01 - $2.87
Previous Close$0.02
Volume5.48K
Average Volume (3M)38.99K
Market Cap
$358.50K
Enterprise Value$114.96M
Total Cash (Recent Filing)$200.00K
Total Debt (Recent Filing)$114.80M
Price to Earnings (P/E)―
Beta1.03
Next Earnings
Jun 03, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-3.13
Shares Outstanding23,900,031
10 Day Avg. Volume19,690
30 Day Avg. Volume38,995
Standard Deviation0.37
R-Squared0.00281
Alpha-0.12
Financial Highlights & Ratios
Price to Book (P/B)-0.00400
Price to Sales (P/S)0.07
Price to Cash Flow (P/CF)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue6.47
Enterprise Value/Gross Profit18.67
Enterprise Value/Ebitda-2.02
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Impel Pharmaceuticals News
PremiumCompany Announcements
Impel Pharmaceuticals’ Asset Sale Marks Restructuring MilestoneOwnership Overview
53.58% Insiders
2.83% Mutual Funds
11.55% Other Institutional Investors
32.04% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
IMPLQ FAQ
What was Impel Pharmaceuticals’s price range in the past 12 months?
Impel Pharmaceuticals lowest stock price was <$0.01 and its highest was $2.87 in the past 12 months.
What is Impel Pharmaceuticals’s market cap?
Currently, no data Available
When is Impel Pharmaceuticals’s upcoming earnings report date?
Impel Pharmaceuticals’s upcoming earnings report date is Jun 03, 2024 which is 173 days ago.
How were Impel Pharmaceuticals’s earnings last quarter?
Currently, no data Available
Is Impel Pharmaceuticals overvalued?
According to Wall Street analysts Impel Pharmaceuticals’s price is currently Overvalued.
Does Impel Pharmaceuticals pay dividends?
Impel Pharmaceuticals does not currently pay dividends.
What is Impel Pharmaceuticals’s EPS estimate?
Impel Pharmaceuticals’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Impel Pharmaceuticals have?
Impel Pharmaceuticals has 23,900,030 shares outstanding.
What happened to Impel Pharmaceuticals’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Impel Pharmaceuticals?
Among the largest hedge funds holding Impel Pharmaceuticals’s share is Gilder Gagnon Howe & Co LLC.. It holds Impel Pharmaceuticals’s shares valued at N/A.
---
Impel Pharmaceuticals Stock Smart Score
Company Description
Impel Pharmaceuticals
Impel NeuroPharma Inc is a late-stage pharmaceutical company focused on utilizing its proprietary technology to develop and commercialize transformative therapies for patients suffering from diseases with high unmet medical needs, with an initial focus on diseases of the central nervous system. Its pipeline of proprietary product candidates includes INP107 for the treatment of OFF episodes in Parkinson's Disease.
---
IMPLQ Earnings Call
Q1 2023
0:00 / 0:00
---
IMPLQ Stock 12 Month Forecast
Average Price Target
―Technical Analysis
---